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A B S T R A C T
The aims of this study were to determine the presence of respiratory syncytial virus (RSV) 
and to assess the clinical features of the disease in infants with acute low respiratory tract 
infection hospitalized at pediatric intensive care units (PICU) of two university teaching 
hospitals in São Paulo State, Brazil. Nasopharyngeal secretions were tested for the RSV by the 
polymerase chain reaction. Positive and negative groups for the virus were compared in terms 
of evolution under intensive care (mechanical pulmonary ventilation, medications, invasive 
procedures, complications and case fatality). Statistical analysis was performed using the 
Mann Whitney and Fisher’s exact tests. A total of 21 infants were assessed, 8 (38.1%) of whom 
were positive for RSV. The majority of patients were previously healthy while 85.7% required 
mechanical pulmonary ventilation, 20/21 patients presented with at least one complication, 
and the fatality rate was 14.3%. RSV positive and negative groups did not differ for the variables 
studied. Patients involved in this study were critically ill and needed multiple PICU resources, 
independently of the presence of RSV. Further studies involving larger cohorts are needed to 
assess the magnitude of the impact of RSV on the clinical evolution of infants admitted to the 
PICU in our settings. 
poorer evolution, many ICU patients were previously healthy.5-10 
The aims of this study was to determine the presence of RSV 
and the clinical features of this infection in infants with 
ALRTI hospitalized in the pediatric intensive care unit (PICU). 
A prospective descriptive and analytical study was conducted 
in infants aged between zero and 12 months with ALRTI 
hospitalized in the PICU of two University teaching hospitals in 
the Campinas region of São Paulo state, Brazil in 2004, 2007 and 
2008. Collection was performed between the months of April 
and September, a period previously reported to be associated 
with the highest incidence of the virus in the region.4,15
Respiratory  syncyt ia l  v i rus  (RSV)  leads  to  acute 
lower respiratory tract infection (ALRTI) in approximately 
10% of infant cases1,2 and requires mechanical pulmonary 
ventilation (MPV) in 7% to 21% of hospitalized patients.3,4 
A review of recent articles retrieved from the Medline 
database using the search words “Respiratory Syncytial Virus 
Intensive Therapy Infants” involving different study cohorts 
showed that newborns and young infants with RSV are at 
greater risk for MPV, longer hospital stay and higher incidence 
of complications.5-14 Although the presence of comorbidities 
(pneumonia, cardiopathy and prematurity) is associated to 
Brief Communication
Respiratory syncytial virus, infants and intensive therapy   
Ieda Aparecida Correa Buenoa, Adriana Gut Lopes Riccettoa*, André Moreno Morcilloa, 
Clarice Weis Arnsb, Emílio Carlos Elias Baracata 
aDepartment of Pediatrics, School of Medical Sciences, Universidade Estadual de Campinas, Campinas, SP, Brazil 
bVirology Laboratory, Department of  Genetics, Evolution and Bioagents, Institute of Biology, Universidade Estadual de Campinas , SP,  Brazil
  * Corresponding author at: Universidade Estadual de Campinas, Cidade Universitária Zeferino Vaz, Barão Geraldo, 13083-970, São Paulo, 
 SP, Brazil  
 E-mail address: aglriccetto@gmail.com (Adriana Gut Lopes Riccetto) 
© 2012 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
Este é um artigo Open Access sob a licença de CC BY-NC-ND
 BRAZ J INFECT DIS. 2012;16(1):86-89 87
The inclusion criteria were infants between 0 and 12 
months of life and hospitalized in the PICU due to ALRTI. 
The sole criterion for exclusion was onset of symptoms more 
than seven days prior to admission. 
The diagnosis of ALRTI was reached based on clinical criteria 
(fever, cough, tachypnea, rales or wheezes on auscultation), 
supplemented by radiological (hyperinflation, opacities) and 
gasometric (hypoxemia, hypercapnia, respiratory acidosis) 
criteria. The combination of these findings determined the 
need for MPV or otherwise in these patients according to 
specific medical protocols.16,17 Nasopharyngeal secretions 
were collected by aspiration from all patients during the 
first three days of admission. The material obtained was 
analyzed by the polymerase chain reaction (PCR) molecular 
method.18 Patients were divided into RSV positive and RSV 
negative groups and assessed for gender, age on admission, 
previous diseases, length of PICU stay, need for/time on MPV, 
use of medications, and invasive procedures. During the 
PICU stay, patients were assessed for prognostic factors of 
worse evolution on MPV by calculating the ventilation index 
(VI = peak inspiratory pressure x mechanical respiratory 
rate/1000) and partial oxygen pressure/fraction of inspired 
oxygen (PaO2/FIO2), and by examining the worse gasometry 
value of the first day of MPV.19 Complications were registered 
after the first day of ICU stay and grouped into cardiologic 
(myocarditis with cardiac insufficiency or arrhythmias), renal 
(acute renal insufficiency), neurologic (encephalitis with 
convulsions and coma), hydroelectrolytic (acidosis, sodium 
potassium, calcium disturbances), hematologic (anemia, 
leukopenia, plateletopenia) and respiratory (atelectasis, pleural 
stroke, pneumothorax) problems. 
Data were stored using the Excel  program and 
analysis performed by version 8.2 of the SAS (Statistical 
Analysis System) software (SAS Institute INC, 1999-2001, Cary, NC, 
USA). The Mann Whitney and Fisher’s exact tests were employed 
for statistical analysis adopting a significance level of 0.05.
A signed term of informed consent was provided 
by the guardians of all patients. This project was previously 
approved by the Research Ethics Committee of the School of 
Medical Sciences of the Universidade Estadual de Campinas 
(UNICAMP) under process number 076/2003 and was 
conducted in accordance with the ethical principles of the 
World Medical Association and Declaration of Helsinki.
Results given are based on the analysis of 21 infants 
aged between zero and 12 months hospitalized in the PICU 
for ALRTI. Regarding patient profile, median age was 2.4 
months, 12 subjects were male (52.2%) and eight (38.1%) tested 
positive on PCR for RSV. Comparison of the RSV-positive and 
RSV-negative groups by the Mann-Whitney test revealed no 
difference in the variables age on admission (p = 0.601) or 
length of PICU stay (p = 0.133). The majority of patients were 
previously healthy (57.1%) whereas 9/21 (42.9%) had previous 
diseases (acquired immunodeficiency, genetic syndromes, 
cardiopathies). Similarly, the two groups did not differ for 
previous diseases (p = 0.200). A total of 18/21 (85.7%) patients 
required mechanical pulmonary ventilation during the PICU 
stay. No difference between the study groups was found for 
time on ventilatory support (p = 0.762, Fisher’s exact test), and 
ventilation index (p = 0.427, Mann- Whitney test) or PaO2/FiO2 
(p = 0.384, Mann-Whitney Test). With regard to medication use 
during PICU stay, no difference was found in use of endovenous 
corticosteroids, different types of antibiotics, vasoactive drugs or 
continuous sedation with benzodiazepines or opioids (p > 0.05). 
The patients were underwent a variety of invasive procedures: 
venous catheter insertion (by deep venipuncture/Intracath®, 
percutaneous puncture/PICC® and vein dissection/phlebotomy); 
use of vesical relief and delay probe; chest drainage. In terms 
of frequency of these procedures, a significant difference was 
found between groups only for the phlebotomy procedure which 
was more frequent in RSV-positive patients (p = 0.042).
During the PICU stay, 20/21 patients had complications, 
predominantly respiratory problems (15/21; 71.4%) although 
no difference between RSV-positive and RSV-negative groups 
was evident (Table 1). Concerning fatalities, one death occurred 
in the RSV-positive group and two deaths in the RSV-negative 
group (3/21, 14.3%), a non-significant difference between 
the groups (p = 0.510, Fisher’s exact test). The deaths occurred 
in young infants that evolved clinically with cardiovascular 
and infectious complication, one of whom had Down’s syn-
drome. Patient characteristics are shown in Table 2.
Complication RSV + RSV - Total p*
Cardiologic (myocarditis with cardiac insufficiency or arrhythmias) (yes/no) 1/7 3/10 4/17 0.501
Renal (renal insufficiency) (yes/no) 0/8 1/12 1/20 0.619
Neurological (encephalitis with seizure or coma) (yes/no) 1/7 1/12 2/19 0.628
Hydroelectrolytic (metabolic acidosis, disturbances in sodium, potassium or calcium) (yes/no) 2/6 1/12 3/18 0.315
Hematologic (anemia, leukopenia, thrombocytopenia) (yes/no) 5/3 7/6 12/9 0.527
Respiratory  (atelectasis, plural stroke, pneumothorax) (yes/no) 6/2 9/4 15/6
0.590
RSV, respiratory syncytial virus; *p = Fisher’s exact test.
Table 1 - Complication types during clinical evolution among infants between zero and 12 months of age hospitalized  
at the Pediatric Intensive Care Unit for acute lower respiratory tract infection, in respiratory syncytial virus positive and 
negative groups
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The overall result of the present study was that clinical 
pictures among the cohort studied were no more severe 
in RSV-positive patients than RSV-negative individuals. In 
the present population, although the proportion of males 
and the age group were consistent with those of a similar 
study,15 RSV-positive and negative patients were compara-
ble in terms of PICU stay, MPV and complications, a finding 
that contrasts with earlier reports.6,8,11,14 However, it should 
be noted that the present study included infants only up to 
12 months of age and that the worse evolution seen in RSV-
positive patients affected mainly young infants, particularly 
newborns.5,8 Another noteworthy point is that comparison 
of our results with those in the literature was hampered by 
the fact that the present study included three forms of clini-
cal presentation (bronchiolitis, pneumonia and pneumonia 
plus bronchiolitis) whereas the majority of earlier studies 
considered only patients with bronchiolitis.1,2,16 This broader 
inclusion was based on results of a previous study involving 
a large cohort (n = 144) performed in the same hospitals that 
showed a predominance of the bronchiolitis-plus-pneumo-
nia form among patients hospitalized for RSV.20 Akin to the 
findings of other authors,10 the present cohort comprised 
patients that were predominantly previously healthy (57.1%). 
In contrast to other cohorts investigated, the patients with 
previous diseases in the present study did not have worse 
evolution.6,8,11,14 This finding might be explained by the small 
number of patients included in the study. 
In the present study sample patients were critically ill 
and needed multiple PICU resources, independently of the 
presence of RSV. 
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